Huahaipharm | Briefing, News, Analysis, Research, Data

Huahaipharm

Huahaipharm especially in the field of cardiovascular Puri and Sartan drugs'

Zhejiang Huahai Pharmaceutical Co., Ltd. was founded in 1989 and is a pharmaceutical company integrating pharmaceutical preparations and APIs. The company is a leading enterprise in the domestic specialty API industry, especially in the field of cardiovascular Puri and Sartan drugs, the company has the core technology and is currently the largest supplier of Puri and Sartan drugs in the world with the largest number of production varieties and leading technical level.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Feb 1, 2001

HQ location

Zhejiang, China

Legal name

Zhejiang Huahai Pharmaceutical Co., Ltd.

Website

http://www.huahaipharm.com

600521@huahaipharm.com

Employees

5001-10000

All
News
Analysis
Research

Briefing Feb 16, 2023 12:51 PM · Healthcare

Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A

Briefing Feb 07, 2023 12:11 PM · Healthcare

ForLong Biotech Nets Over CNY 100 Mn in Series A

In-depth

Healthcare

Chinese Company Turned the Tables on Domestic Cell Culture Media Market

In this article, EqualOcean mainly introduce the history, competition, lead company, future trend in domestic cell culture media industry.

Feb 02, 2023 10:45 AM

Briefing Feb 07, 2023 10:59 AM · Healthcare

CytoCan Corp. Nets CNY 10 Mn in Seed Round

Briefing May 24, 2022 03:00 PM · Healthcare | Automotive

Toyota: 16 production lines in 10 factories in Japan shut down for up to 5 days

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Technology, Healthcare, Financials

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing May 20, 2022 05:44 PM · Technology | Consumer Staples | Healthcare

State Administration of market supervision: extending the use time of residual packaging materials of solid beverage enterprises

Briefing Apr 28, 2022 03:55 PM · Technology | Consumer Staples | Healthcare

First travel hotel: net loss of 232 million yuan in the first quarter

Briefing Apr 18, 2022 05:34 PM · Technology | Consumer Staples | Consumer Discretionary

Huahai pharmaceutical: the net profit in the first quarter is expected to decrease by 41% - 50% year-on-year

Briefing Feb 21, 2022 04:59 PM · Technology | Communication | Healthcare

China Mobile: a net increase of 4.497 million mobile users in January 2022

Healthcare

HealthGuard: Registration of Indonesian Subsidiary, Investment in Producing HPV Vaccine

Jun 20, 2024 03:12 PM

Healthcare

SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year

EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.

Jun 06, 2024 06:18 PM

Briefing Jan 20, 2022 04:20 PM · Consumer Staples | Healthcare | Industrials

The 7700 emergency code of the first flight from Beijing to Chengdu has landed safely at Shuangliu Airport

Briefing Jan 19, 2022 10:40 AM · Healthcare | Industrials | Automotive

Midea Group: it will provide vehicle level solutions for new energy vehicles in the future

Briefing Jan 17, 2022 04:19 PM · Technology | Consumer Staples | Healthcare

Lege Co., Ltd.: a wholly-owned subsidiary recognized as a high-tech enterprise

Healthcare

Yilite Technology Completes A+ Round Financing of CNY 100 Million

Yilite Technology has secured over CNY 100 million in two rounds of financing within the year.

May 15, 2024 03:21 PM

Healthcare

Cellatopia Secures Nearly CNY Ten Mn in Seed Funding

EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).

Apr 18, 2024 01:25 PM

Briefing Jan 06, 2022 04:09 PM · Technology | Consumer Staples | Healthcare

New Beiyang: the subsidiary won the bid for the procurement project of China Post super teller machine

Briefing Dec 27, 2021 04:29 PM · Technology | Consumer Staples | Healthcare

Jinling Sports: 300 shares purchased by employee supervisor Xu Yan

Briefing Dec 09, 2021 11:59 AM · Technology | Healthcare

The first domestic targeted il-36r monoclonal antibody was administered to the first subject in New Zealand

Briefing Aug 26, 2021 06:31 PM · Healthcare

Huahai pharmaceutical: the net profit in the first half of the year was 516 million yuan, a year-on-year decrease of 10.84%

EqualOcean Analysis